"10.1371_journal.pone.0109973","plos one","2014-11-12T00:00:00Z","Sofia Khan; Dario Greco; Kyriaki Michailidou; Roger L Milne; Taru A Muranen; Tuomas Heikkinen; Kirsimari Aaltonen; Joe Dennis; Manjeet K Bolla; Jianjun Liu; Per Hall; Astrid Irwanto; Keith Humphreys; Jingmei Li; Kamila Czene; Jenny Chang-Claude; Rebecca Hein; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Olivia Fletcher; Julian Peto; Isabel dos Santos Silva; Nichola Johnson; Lorna Gibson; Zoe Aitken; John L Hopper; Helen Tsimiklis; Minh Bui; Enes Makalic; Daniel F Schmidt; Melissa C Southey; Carmel Apicella; Jennifer Stone; Quinten Waisfisz; Hanne Meijers-Heijboer; Muriel A Adank; Rob B van der Luijt; Alfons Meindl; Rita K Schmutzler; Bertram Müller-Myhsok; Peter Lichtner; Clare Turnbull; Nazneen Rahman; Stephen J Chanock; David J Hunter; Angela Cox; Simon S Cross; Malcolm W R Reed; Marjanka K Schmidt; Annegien Broeks; Laura J V a n't Veer; Frans B Hogervorst; Peter A Fasching; Michael G Schrauder; Arif B Ekici; Matthias W Beckmann; Stig E Bojesen; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Javier Benitez; Pilar M Zamora; Jose I A Perez; Christopher A Haiman; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Paul D P Pharoah; Alison M Dunning; Mitul Shah; Robert Luben; Judith Brown; Fergus J Couch; Xianshu Wang; Celine Vachon; Janet E Olson; Diether Lambrechts; Matthieu Moisse; Robert Paridaens; Marie-Rose Christiaens; Pascal Guénel; Thérèse Truong; Pierre Laurent-Puig; Claire Mulot; Frederick Marme; Barbara Burwinkel; Andreas Schneeweiss; Christof Sohn; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Irene L Andrulis; Julia A Knight; Sandrine Tchatchou; Anna Marie Mulligan; Thilo Dörk; Natalia V Bogdanova; Natalia N Antonenkova; Hoda Anton-Culver; Hatef Darabi; Mikael Eriksson; Montserrat Garcia-Closas; Jonine Figueroa; Jolanta Lissowska; Louise Brinton; Peter Devilee; Robert A E M Tollenaar; Caroline Seynaeve; Christi J van Asperen; Vessela N Kristensen; kConFab Investigators; Australian Ovarian Cancer Study Group; Susan Slager; Amanda E Toland; Christine B Ambrosone; Drakoulis Yannoukakos; Annika Lindblom; Sara Margolin; Paolo Radice; Paolo Peterlongo; Monica Barile; Paolo Mariani; Maartje J Hooning; John W M Martens; J Margriet Collée; Agnes Jager; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Graham G Giles; Catriona McLean; Hiltrud Brauch; Thomas Brüning; Yon-Dschun Ko; The GENICA Network; Hermann Brenner; Aida Karina Dieffenbach; Volker Arndt; Christa Stegmaier; Anthony Swerdlow; Alan Ashworth; Nick Orr; Michael Jones; Jacques Simard; Mark S Goldberg; France Labrèche; Martine Dumont; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Arto Mannermaa; Ute Hamann; Georgia Chenevix-Trench; Carl Blomqvist; Kristiina Aittomäki; Douglas F Easton; Heli Nevanlinna","Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Finnish Institute of Occupational Health, Helsinki, Finland; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia; Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany; Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia; Department of Pathology, The University of Melbourne, Melbourne, Australia; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany; Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany; Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; Max Planck Institute of Psychiatry, Munich, Germany; Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany; Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California Los Angeles, California, United States of America; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii, United States of America; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Vesalius Research Center (VRC), VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium; Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; Research Oncology, Division of Cancer Studies, Kings College London, Guys Hospital, London, United Kingdom; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; Clinical Science Institute, University Hospital Galway, Galway, Ireland; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine, and the Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michaels Hospital, Toronto, Ontario, Canada; Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus; Department of Epidemiology, University of California Irvine, Irvine, California, United States of America; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, Netherlands; Department of Surgical Oncology, Leiden University Medical Center, Leiden, Netherlands; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), University of Oslo, Oslo, Norway; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Peter MacCallum Cancer Center, Melbourne, Australia; QIMR Berghofer Medical Research Institute, Brisbane, Australia; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America; Roswell Park Cancer Institute, Buffalo, New York, United States of America; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland; Anatomical Pathology, The Alfred Hospital, Melbourne, Australia; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bochum, Germany; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute for Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Saarland Cancer Registry, Saarbrücken, Germany; Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, United Kingdom; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada; Department of Medicine, McGill University, Montreal, Canada; Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada; Départements de Santé Environnementale et Santé au Travail et de Médecine Sociale et Préventive, Université de Montréal, Montreal, Quebec, Canada; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland; School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia","Conceived and designed the experiments: HN DG GCT AC RLM DFE SK KM JCC AD MS MGC PH. Performed the experiments: SK DG KM RLM DFE. Analyzed the data: SK DG KM RLM HN DFE. Contributed reagents/materials/analysis tools: SK HN DG KM GCT AC RLM PDPP UH MKS A. Meindl RW TH CB K. Aaltonen GGG DFE PAF MJH ILA H. Brauch QW EJS H. Brenner AKD MSG FL TAM K. Aittomäki J. Liu PH AI KH J. Li KC JCC RH AR PS DFJ OF JP IdSS NJ LG ZA JLH HT M. Bui EM DFS MCS CA J. Stone HMH MAA RBvdL A. Mannermaa RKS BMM PL CT NR SJC DJH SSC MWRR AB LJVV FBH MGS ABE MWB SEB BGN SFN HF PMZ JIAP J. Benitez CAH BEH FS LLM AMD MS RL J. Brown FJC XW CV JEO DL MM RP MRC PG TT PLP C. Mulot FM A. Schneeweiss C. Sohn BB IT MJK NM JAK ST AMM NVB NNA TD HAC HD ME MGC JF J. Lissowska LB PD RAEMT C. Seynaeve CJvA VNK SS AET CBA DY AL SM PR PP M. Barile PM JWMM JMC A. Jager A. Jakubowska J. Lubinski KJB KD C. McLean TB YDK VA C. Stegmaier A. Swerdlow AA NO MJ J. Simard MD KP AJV MG VK MKB JD VMK JMH kConFab Investigators Australian Ovarian Cancer Study Group The GENICA Network. Wrote the paper: SK HN RLM AC. Provided critical review of the manuscript: SK HN DG KM GCT AC RLM PDPP UH MKS A. Meindl RW TH CB K. Aaltonen GGG DFE PAF MJH ILA H. Brauch QW EJS H. Brenner AKD MSG FL TAM K. Aittomäki J. Liu PH AI KH J. Li KC JCC RH AR PS DFJ OF JP IdSS NJ LG ZA JLH HT M. Bui EM DFS MCS CA J. Stone HMH MAA RBvdL A. Mannermaa RKS BMM PL CT NR SJC DJH SSC MWRR AB LJVV FBH MGS ABE MWB SEB BGN SFN HF PMZ JIAP J. Benitez CAH BEH FS LLM AMD MS RL J. Brown FJC XW CV JEO DL MM RP MRC PG TT PLP C. Mulot FM A. Schneeweiss C. Sohn BB IT MJK NM JAK ST AMM NVB NNA TD HAC HD ME MGC JF J. Lissowska LB PD RAEMT C. Seynaeve CJvA VNK SS AET CBA DY AL SM PR PP M. Barile PM JWMM JMC A. Jager A. Jakubowska J. Lubinski KJB KD C. McLean TB YDK VA C. Stegmaier A. Swerdlow AA NO MJ J. Simard MD KP AJV MG VK MKB JD VMK JMH kConFab Investigators Australian Ovarian Cancer Study Group The GENICA Network. Approved the final version of the manuscript: SK HN DG KM GCT AC RLM PDPP UH MKS A. Meindl RW TH CB K. Aaltonen GGG DFE PAF MJH ILA H. Brauch QW EJS H. Brenner AKD MSG FL TAM K. Aittomäki J. Liu PH AI KH J. Li KC JCC RH AR PS DFJ OF JP IdSS NJ LG ZA JLH HT M. Bui EM DFS MCS CA J. Stone HMH MAA RBvdL A. Mannermaa RKS BMM PL CT NR SJC DJH SSC MWRR AB LJVV FBH MGS ABE MWB SEB BGN SFN HF PMZ JIAP J. Benitez CAH BEH FS LLM AMD MS RL J. Brown FJC XW CV JEO DL MM RP MRC PG TT PLP C. Mulot FM A. Schneeweiss C. Sohn BB IT MJK NM JAK ST AMM NVB NNA TD HAC HD ME MGC JF J. Lissowska LB PD RAEMT C. Seynaeve CJvA VNK SS AET CBA DY AL SM PR PP M. Barile PM JWMM JMC A. Jager A. Jakubowska J. Lubinski KJB KD C. McLean TB YDK VA C. Stegmaier A. Swerdlow AA NO MJ J. Simard MD KP AJV MG VK MKB JD VMK JMH kConFab Investigators Australian Ovarian Cancer Study Group The GENICA Network. Administrative technical or material support: MKB JD MS RL.","The authors have declared that no competing interests exist.","2014","11","Sofia Khan","SK",164,FALSE,13,5,6,4,TRUE,TRUE,TRUE,102,"6;10;13;14;15;17;19;20;21;22;23;24;25;27;28;30;31;34;35;36;40;41;42;43;44;45;46;48;49;53;57;58;59;60;61;62;63;66;67;68;73;74;75;76;77;78;79;80;81;82;83;84;85;86;87;89;90;91;92;93;96;98;99;102;103;105;106;107;108;110;112;113;115;118;120;121;124;125;126;127;130;131;132;133;134;135;136;137;139;142;145;146;147;149;150;151;152;154;155;156;157;161",TRUE
